Clinuvel Pharmaceuticals | CUV - Operating Expenses

Stock Price
8.95
Daily Change
-0.09 -1.00%
Monthly
-8.49%
Yearly
-17.21%
Q2 Forecast
8.87

Clinuvel Pharmaceuticals reported AUD23.42M in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Avita Medical AUD 28.02M 1.55M Dec/2025
Medical Developments International AUD 21.61M 11.59M Dec/2025
Mesoblast USD 82.31M 26.16M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Pacific Edge NZD 25.34M 2.03M Dec/2025
Paradigm Biopharmaceuticals AUD 21.85M 13.36M Dec/2025
PYC Therapeutics AUD 33.63M 14.33M Dec/2025
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025